Therefore, these results show that Tyro3 is the main TAM receptor coupled to Erk signalling in cancer cells, but is also able to diversify its signalling pathway interactions, as well as ligand sensitivity, when present as the sole TAM receptor at a sufficient expression level in cancer cells. The gene discussed is TYRO3; the disease is cancer.